Northwestern Mutual Wealth Management
AIM

Northwestern Mutual Wealth Management’s AIM ImmunoTech AIM Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6
Closed -$162 – 3977
2024
Q3 		$162 Buy
+6
New +$200 ﹤0.01% 3456

Other funds holding AIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northwestern Mutual Wealth Management's AIM Position: Q4 2024 in Review

Northwestern Mutual Wealth Management sold out of AIM ImmunoTech (AIM) in Q4 2024, closing a stake of 6 shares — an estimated $162 sold.

Northwestern Mutual Wealth Management first reported a position in AIM in Q3 2024 and held it in 1 quarter. The position peaked at $162 in Q3 2024. 32 funds tracked by Wall St. Rank hold AIM as of Q4 2024.

  • Northwestern Mutual Wealth Management reported no remaining AIM ImmunoTech position as of Q4 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 6 AIM ImmunoTech shares in Q4 2024, an estimated $162.
  • Northwestern Mutual Wealth Management first reported a position in AIM ImmunoTech in Q3 2024 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's AIM ImmunoTech position peaked at $162 in Q3 2024.
  • 32 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q4 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2024, filed 11 Feb 2025.